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Out of the one hundred and fifty stool human samples screened for the prevalence of Plesiomonas 
shigelloides, only 3 (2%) were positive for the organisms. The positive isolates were used to produce P. 
shigelloides antibody in experimental animals (rabbits). Autopsy revealed marked inflammation of the 
liver, spleen and the kidney in the experimental animals not protected with the antibodies. This study 
showed that the trial rabbits were suitable for the production of antibodies against P. shigelloides, and 
further demonstrated the diagnostic and protective potentials of the antibodies. 
 





Plesiomonas shigelloides has been recognized recently 
as potential human and animal pathogen. Plesiomonads 
are Gram-negative, motile, non-spore forming bacilli 
facultative anaerobic and oxidase positive. Since 2001, 
P. shigalloides has been reported to belong to the family 
Enterobacteraceae (CDC, 2003). The primary reservoirs 
for this bacterium are fresh and estuarine water, mainly in 
temperature climates. This organism was isolated in 1947 
by Ferguson and Henderson (1947), who named it C27. 
Since then, it has been variously known as Plesiomonas 
shigelloides (Basder, 1954), Pseudomonas michignai, 
Aeromonas shigelloides (Ewing et al., 1961), Fergusonia 
shigelloides (Sebabld and Veron, 1963) and Vibrio 
shigelloides (Heridric et al, 1971). Plesiomonas 
shigelloides normally inhabits surface waters and soil in 
temperate and tropical areas of the world and is not 
considered part of the indigenous microbiota of the 
human gastrointestinal tract (Arai et al., 1980). 
Over the years there have been a number of reports on 
the isolation of P. shigelloides from clinical specimens 
(Davis et al., 1988). The increased level of awareness 
and seeming pathogenic roles of these organisms have 
recently generated interest in their study world-wide. P. 
shigelloides has been implicated in several large 
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Tsukamoto et al., 1978) and in sporadic cases of 
diarrhoeal illness (Reinhandt and George, 1985). Its role 
as gastrointestinal pathogen in human is still unclear 
(Herrington et al., 1987). Two features thought to play 
key roles in the regulation of gastrointestinal infection by 
enteropathogenic bacteria are gastric acidity and the 
presence of resident microbial flora in the lower gut. P. 
shigelloides associated diarrhea has occurred in 
epidemics but also in isolated cases. It has as well been 
implicated as an aetiological agent of food poisoning in 
many parts of the world, where it has been described 
after uncooked-shellfish consumption. P. shigelloides has 
been mentioned as a cause of traveller’s diarrhoea 
(Holmberg et al., 1986) and has also been isolated in the 
immuno-compromised or persons seriously ill with 
cancer, blood disorders or hepatobiliary disease (Cutis et 
al., 1978; CDC, 2003). Tsukamoto et al. (1978) reported 
on the serology of P. shigelloides showed it to possess 
somatic (O) and flagella (H) antigens, which have been 
useful in the investigation of diarrhoeal epidemics. Early 
case report has demonstrated the potential pathogenicity 
of P. shigelloides as a secondary pathogen of low 
virulence. 
P. shigelloides gastroenteritis is usually a mild self 
limiting disease with fever, chills, abdominal pain, 
nausea, diarrhoea or vomiting. Symptoms may begin 20-
24 h after consumption of contaminated food or water. 
Diarrhoea is watery, non-mucoid and non-bloody, in 
severe cases, diarrhoea may be  greenish-yellow,  foamy  
and blood tinged.  Duration  of  illness  in  healthy  people 
 




may be 1 to 7days (CDC, 2003). 
This paper was aimed at isolating P. shigelloides from 
stool to produce antibodies in rabbits and to determine 
the protective effect of the anti-antibodies against 
experimental infection with the organism. 
 
 




One hundred and fifty asymptomatic and symptomatic 
(diarrhoeagenic) stool samples from adults and children were 
collected form Otibhor Okhae Teaching Hospital, Irrua and St. 
Camilius Hospital, Uromi. Upon collection, the samples were 
screened for the presence of P. shigelloides using xylose sodium 
deoxcycholate citrate agar, which is selective for P. shigelloides. 
The plates were incubated at 37°C for 24 h under anaerobic 
conditions. Upon incubation, the cultures were examined for the 
growth of P. shigelloides, which was identified using a previously 
described method of Alabi and Odugbemi (1990). 
The Gram reaction as well as morphological and biochemical 




Production of anti-Pl. shigelloides antibody 
 
For the study, experimental animals (rabbits) were obtained from 
the Rubber Research Institute, Iyanomo, Benin City and Irrua, Edo 
State. The experimental animals were fed on commercial diet, 
lemon grass and tap water regularly. 
Colloidal carbon particles in the form of Indian ink were used as a 
blockading agent against phagocytes. The dilution of the colloidal 
carbon was done as follows; 0.01 g of agar was dissolved in 100 ml 
saline from the mixture. Aliquots of 0.5 ml were mixed with 0.5 ml 
Indian ink which makes up the colloidal carbon particles, and 0.4 ml 
of the final suspension was used to inject the experimental animals. 
Cultures of P. shigelloides, both local and standard strain (ATCC 
14029), were inoculated onto Petri dishes containing xylose sodium 
deoxycholate citrate agar and incubated at 37°C for 24 h. The 
cultures were transferred to 9 ml phosphate butter saline (PBS) (pH 
7.8), washed twice and finally resuspended in PBS at 1×7
10
 cfu/ml. 
The experimental animals (10) weighing 3.0 to 3.5 kg were 
intravenously injected with increasing dose of P. shigelloides 
antibody raised against standard strain (ATCC 14029) and local 
strains, at 4 to 5 days intervals for four weeks. Five days after the 
last injection, the animals were bled and serum was separated after 
centrifugation, to obtain anti-P. shigelloides antiserum. 
 
 
Passive protective test 
 
The experimental animals (rabbits) were immunized 
intraperitionally. Ten of the experimental animals were injected with 
P. shigelloides and anti-P. shigelloides antibody, another set of 10 
experimental animals were injected with P. shigelloides, colloidal 
carbon particles and anti-P. shigelloides, antibody. The third group 
of 10 experimental animals were injected with P. shigelloides and 
colloidal carbon particles while the fourth group of 10 experimental 
animals were injected only with P. shigelloides and finally, the last 
group of 10 experimental animals were injected only with colloidal 
carbon particles. The various inoculations were a dose each and 





Table 1. Prevalence of P. shigelloides among symptomatic and 




No and % of 
occurrence 
Symptomatic  84 3 (3.57%) 
Asymptomatic 66 0 (0%) 






The study revealed that out of a total of 150 stools 
screened for the prevalence of P. shigelloides, only 3 
(2%) were positive. All the three isolates were obtained 
from stools of patients with diarrhoea (Table 1). The local 
and standard strains (ATCC 14209) used in this study 
were also used to produce P. shigelloides antisera. Out 
of the 10 experimental animals injected with P. 
shigelloides and anti-P. shigelloides antibody only 1 
(10%) died, while those injected with P. shigelloides, 
colloidal carbon particles and anti-P. shigelloides 
antibody two (20%) death were recorded. Of those 
injected with P. shigelloides and colloidal carbon 
particles, 7 (70%) death were recorded and 5 (5%) was 
recorded for those injected only with P. shigelloides. 
Finally no death was recorded for those injected with 
colloidal carbon particles only (Table 2). 
Autopsy examination of the experimental animals 
(rabbits) showed inflammation of the kidney, liver and 
spleen. These organs were normal with control 





P. shigelloides which has been reported, as an 
aetiological agent of diarrhoea (Alabi and Odugbemi, 
1990), is also responsible for the cause of several 
disease states including septicemia and colitis. In this 
study a total of one hundred and fifty stool samples of 
adult and children were screened for the prevalence of P. 
shigelloides and only 3 (2%) were positive. 
It is, therefore, interesting to note that antisera against 
local isolates of P. shigelloides were successfully 
produced in rabbits and this is consistent with previous 
reports (Obi and Coke, 1988, 1989). The avidity of this 
antibody compares favourably with antisera using an 
international isolate (ATCC 14209). The titre of both the 
local and standard strain was 
1
/64. The successful 
production of antisera against P. shigelloides is in 
harmony with the scientific self-reliance policy and the 
achievement of health for all in the 21
st
 century. The 
death of the animals injected shows a possible lethality 
for P. shigelloides and that the lethality was enhanced by 
the addition of colloidal carbon particles. Colloidal carbon 
particles have been reported to block macrophages and 
macrophages are  known  to  be  important  factor  in  the  




Table 2. Passive protective effect of anti-P. shigelloides antibody in experimental animals challenged with virulent P. shigelloides. 
 
Inoculation of experimental animals* No. of death % of death 
A. P. shigelloides + anti-P. shigelloides antibody 1 10 
B. P. shigelloides + colloidal carbon particles + anti-P.shigalloides antibody 2 20 
C. P. shigelloides + colloidal carbon particles 7 70 
D. P. shigelloides only 5 50 
E. colloidal carbon particles - - 
           




defence mechanism of animals (Obi and Coker, 1989). 
The injection of colloidal carbon particles did not result in 
the death of the animals, suggesting that its effect on 
macrophages may not be sufficient to cause death. With 
the injection of anti-Plesiomonas shigelloides with P. 
shigelloides and colloidal carbon particles, the lethality 
observed decreased to 20% indicating possible protective 
effect of anti-P. shigelloides antibody. This agrees with 
Obi and Coker (1989), who  reported  that  rats  could  be 
passively protected against Campylobacter jejuni by an 
initial infection of Campylobacter anti-antibody.  
Furthermore, it has been reported that frequent 
injection with a particular antigen may stimulate two types 
of antibody responses, one of which is usually directed 
against the antigen and the other one is directed against 
the antibody. The anti-antibody is involved in the 
regulation of immunity (Klustens and Kohler, 1974). The 
anti-antibody exhibits immunosuppressive properties, 
neutralizing properties and are useful in the regulation of 
immune responses. 
In conclusion, the diagnostic and protective potential of 
the antibodies will serve to provide new frontiers for the 
laboratory diagnosis and passive protection of animals 
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